Volume 24, No 3, Mar 2014

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 24 Issue 3, March 2014: 331-343

ORIGINAL ARTICLES

VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex

Wenjing Zhang^1,*, Yijun Gao^1,*, Peixue Li^1,*, Zhubing Shi¹, Tong Guo¹, Fei Li¹, Xiangkun Han¹, Yan Feng¹, Chao Zheng¹, Zuoyun Wang¹, Fuming Li¹, Haiquan Chen^2,3, Zhaocai Zhou¹, Lei Zhang¹ and Hongbin Ji¹

¹State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Yueyang Road, Shanghai 200031, China
²Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
³Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China Correspondence: Hongbin Ji, E-mail: hbji@sibcb.ac.cn; Lei Zhang, E-mail: RayZhang@sibcb.ac.cn; Zhaocai Zhou,(zczhou@sibcb.ac.cn)

Lung cancer is one of the most devastating diseases worldwide with high incidence and mortality. Hippo (Hpo) pathway is a conserved regulator of organ size in both Drosophila and mammals. Emerging evidence has suggested the significance of Hpo pathway in cancer development. In this study, we identify VGLL4 as a novel tumor suppressor in lung carcinogenesis through negatively regulating the formation of YAP-TEAD complex, the core component of Hpo pathway. Our data show that VGLL4 is frequently observed to be lowly expressed in both mouse and human lung cancer specimens. Ectopic expression of VGLL4 significantly suppresses the growth of lung cancer cells in vitro. More importantly, VGLL4 significantly inhibits lung cancer progression in de novo mouse model. We further find that VGLL4 inhibits the activity of the YAP-TEAD transcriptional complex. Our data show that VGLL4 directly competes with YAP in binding to TEADs and executes its growth-inhibitory function through two TDU domains. Collectively, our study demonstrates that VGLL4 is a novel tumor suppressor for lung cancer through negatively regulating the YAP-TEAD complex formation and thus the Hpo pathway.

10.1038/cr.2014.10

FULL TEXT | PDF

Browse 2295